Pneumatosis intestinalis in systemic sclerosis: navigating diagnostic and therapeutic challenges.

ANZ J Surg

Upper Gastrointestinal Surgery Unit, Eastern Health, Melbourne, Victoria, Australia.

Published: February 2025

Background: Pneumatosis intestinalis, characterised by the presence of intramural bowel gas, is a radiological finding with varied clinical implications, ranging from incidental detection to severe underlying pathology, including bowel ischaemia or perforation. Its association with systemic sclerosis, a connective tissue disorder, remains rare and poorly understood, presenting unique diagnostic and therapeutic challenges.

Methods: A comprehensive literature review was conducted, analysing 34 documented cases of pneumatosis intestinalis associated with systemic sclerosis, examining demographic profiles, clinical features, diagnostic findings, and outcomes of various management strategies.

Results: Pneumatosis intestinalis in systemic sclerosis predominantly occurs in older female patients and is associated with gastrointestinal dysmotility and microvascular damage. Symptoms range from asymptomatic presentations to severe abdominal pain with obstructive symptoms, with the latter increasing the likelihood of surgical intervention. Non-operative management, encompassing antibiotic therapy, oxygen supplementation, and dietary modifications, was associated with favourable outcomes and the lowest mortality. In contrast, surgical intervention, often necessitated by suspected ischemia or perforation, was associated with significantly higher morbidity and mortality.

Conclusion: Pneumatosis intestinalis in systemic sclerosis is a complex clinical entity demanding a nuanced, multi-disciplinary approach to management. Non-operative management should remain the cornerstone of treatment for clinically stable presentations, with surgery reserved for those with clear indications. The absence of standardised guidelines underscores the need for further research to refine diagnostic criteria and therapeutic protocols, ultimately improving long-term outcomes in this complex intersection of gastrointestinal and systemic disease.

Download full-text PDF

Source
http://dx.doi.org/10.1111/ans.70001DOI Listing

Publication Analysis

Top Keywords

pneumatosis intestinalis
20
systemic sclerosis
20
intestinalis systemic
12
diagnostic therapeutic
8
surgical intervention
8
non-operative management
8
systemic
6
pneumatosis
5
sclerosis
5
sclerosis navigating
4

Similar Publications

Necrotizing enterocolitis, a life-threatening surgical condition, is uncommon in the first week of life in preterm neonates. However, the certainty of the risk factors contributing to NEC in preterm neonates during the first week of life remains ambiguous. Our case was amoderately preterm, small for gestation at birth, and delivered by emergency Caesarean section for maternal respiratory distress.

View Article and Find Full Text PDF

The pathophysiology of pneumatosis intestinalis (PI) is poorly understood. PI can be associated with COVID-19 infection. Although this relationship is unclear, proposed mechanisms include direct viral invasion of the mucosa, the use of IL-6 inhibitors, and bowel ischemia.

View Article and Find Full Text PDF

Pneumatosis intestinalis (PI) is a rare but potentially serious gastrointestinal condition with diverse clinical presentations. Pneumatosis intestinalis is identified by the presence of gas in the extraluminal intestinal wall and is further subclassified into benign pneumatosis intestinalis (BPI) and life-threatening pneumatosis intestinalis (LTPI). Prompt and accurate diagnosis, often aided by imaging studies, is crucial to guide appropriate management.

View Article and Find Full Text PDF

Background: Acute mesenteric ischemia is a life-threatening disease. Intrasplenic gas is an extremely rare finding in such cases.

Case Summary: We report a case of a 79-year-old woman with a history of end-stage renal disease on hemodialysis for approximately 20 years, type 2 diabetes mellitus, and atrial fibrillation who presented with two days of epigastric pain.

View Article and Find Full Text PDF

Herein, we present a case of a 53-year-old male who developed pneumatosis intestinalis (PI) while being treated for hepatic encephalopathy with lactulose. Initially, the patient was administered lactulose, the standard treatment for lowering ammonia levels associated with hepatic encephalopathy; however, this approach unexpectedly resulted in the acute onset of severe PI, which persisted even after lactulose was stopped, further compromising the patient's health. Despite intensive management and the cessation of lactulose, the patient's condition rapidly declined, leading to a transition to palliative care and eventual death.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!